Highlights - Strong performance led by India - In US, Albuterol gains are offset by a product recall -Next drug to watch is Advair, used in the management of pulmonary disease - Margins likely to moderate as operating expenses pick up Cipla (CMP: Rs 826; Market cap: Rs 66,606 crore) — the world’s second largest seller of inhalers — has posted another strong quarter, helped by its respiratory portfolio. The resultant cash flow has helped the company repay loan worth $137 million ahead of schedule and Rs...
Moneycontrol Pro Panorama | Banking crisis: Will Powell pause?
Mar 22, 2023 / 03:09 PM IST
In today’s edition of Moneycontrol Pro Panorama: India likely to maintain growth momentum, gold is back in the limelight, China'...
Read NowMoneycontrol Pro Weekender: Between the Fed and a hard place
Mar 11, 2023 / 11:38 AM IST
The Fed is caught between combating inflation and worries over a financial mishap
Read NowTo read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Sharpest Opinions
Access to 230+ exclusive stories per month from our editorial and Experts
+
Have a Global edge with access to content from world renowned experts and journalist
Actionable Insights
Access to 40+ weekly investment ideas including 4 daily technical calls
Virtual Events
Exclusive access to live webinars from market experts on trading and investment strategies
Newsletters
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers